Clinical Trial Update: Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of Cannabidiol Oral Solution (CBD-OS) in children and adolescents with Autism spectrum disorder has completed, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Cannabidiol Oral Solution (CBD-OS) (cannabidiol)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Autism Spectrum Disorder | Phase 2 | Status: COMPLETED | Results posted: 2025-03-30